Platelet membrane fluidity was measured in migraine patients, with and without aura, using the fluorescent probe TMA-DPH (1–[4–(trimethylammonium) phenyl]-6–hexa-1,3,5–triene). Polarization values for TMA-DPH were significantly higher in the platelet membranes of migraine patients (with or without aura) than in those of healthy subjects. These findings signify decreased membrane fluidity and may explain some modifications in receptors, carriers or enzymes described in platelets of migraine patients.
ShinitzkyMPhysiology of membrane fluidity,vol 1.New York:CRC Press,1984:1–51
2.
HouslayMDStanleyKKDynamics of biological membranes.New York:John Wiley,1982
3.
HaningtonEMigraine as a blood disorder: preliminary studies.Adv Neurol1982;33:253–6
4.
CotrimMDFontes RibeiroCAMorgadinhoMTMacedoTRAPlatelets, serotonin and migraine.J Neurochemistry1989;52(Supp):S79C
5.
Fontes RibeiroCACotrimMDMorgadinhoMTRamosISeabra SantosEMacedoTRAMigraine, serum serotonin and platelet 5--HT2 receptorsCephalalgia1990;10:213–19
6.
Headache Classification Committee of the International Headache Society.Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain.Cephalalgia1988;8(Suppl 7):1–96
7.
HeemkerkWMJFeijgeMAHKalafusRHornstraGInfluence of dietary fatty acids on membrane fluidity and activation of rat platelets.Biochim Biophys Acta1989;1004:252–60
8.
KubinaMLanzaFCazenaveJPLaustriatGKuhryJGParallel investigation of exocitosis kinetics and membrane fluidity changes in human platelets with the fluorescent probe trimethylammoniumdiphenylhexatriene.Biochim Biophys Acta1987;901:138–46
9.
KuhryJGDuportailGBronnerCLaustriatGPlasma membrane fluidity measurements on whole living cells by fluorescence anisotropy of trimethylammoniumdiphenylhexatriene.Biochim Biophys Acta1985;845:60–7
10.
FeijgeMHHeemskerkJWMHorstraGMembrane fluidity of non-activated and activated human blood platelets.Biochim Biophys Acta1990;1025:173–8
11.
CaramonaMMCotrimMDFontes RibeiroCAMacedoTRAMonoamine oxidase activity in blood platelets of migraine patients.J Neural Trans1990;32(Suppl):161–4
12.
DavidJLDe ClerckFPlatelets and migraine. In:AmeryWKVan NuetenJMWauquierA edsThe pharmacological basis of migraine therapy.London:Pitman Press,1984:69–80
13.
OxmanTEHitzmannRJSmithRPlatelet membrane lipid composition and the frequency of migraine.Headache1982;22:261–7
14.
KitagawaSKotaniKKametaniFInhibitory mechanism of cis-polyunsaturated fatty acids on platelet aggegation: the relation with their effects on Ca2+ mobilization, cyclic AMP levels and membrane fluidity.Biochim Biophys Acta1990;1054:114–18
15.
ShattilSJAnaya-GalindoRBennettJColemanRWCooperRAPlatelet hypersensitivity induced by cholesterol incorporation.J Clin Invest1975;55:636–43
16.
ShattilSJCooperRAMembrane microviscosity and human platelet function.Biochemistry1976;15:4832–37
